Virtual Event
Advocacy partner: EB Research Partnership
About EB Research Partnership
The mission of EB Research Partnership is to advance life-saving treatments, and ultimately, find a cure for epidermolysis bullosa (EB) by the end of this decade. Secondarily, EBRP’s innovative model is leading the way for all rare diseases. While EB is a rare disease, there are 7,000 rare diseases that affect 1 in 10 people in the world, 95% which have no treatments, that can benefit from the research we fund and our innovative Venture Philanthropy model – both of which are scalable to all rare diseases. Click here to watch The Story of the EB Research Partnership!
Contact: Allison McGettigan – Director of Programs
Phone: 646-844-0902
Email: [email protected]
Upcoming events
About Advocacy Partners
The information above is provided by our partner. Learn more about our advocacy partners here.
Recent Posts
- First DEB patient dosed in trial of KB803 gene therapy eye drops
- Dupilumab treatment eases disease severity, itching in DEB: Small study
- Long-term Vyjuvek safe, effective in dystrophic epidermolysis bullosa
- Traws advances development plans for rigosertib in RDEB-SCC
- Rheacell, AOP partner on stem cell therapy for epidermolysis bullosa